provider portal
Wesper Journal
Obstructive Sleep Apnea (OSA) is a pervasive sleep disorder that affects a significant portion of the population, with approximately 11% of women and 26% of men in America suffering from it. Alarmingly, the vast majority of OSA cases, estimated between...
Continue reading
Chelsie Rohrscheib, Ph.D. Neuroscientist and Head Sleep Expert, WesperJanuary 31, 2024Atrial fibrillation (AFib), a prevalent cardiac arrhythmia affecting millions worldwide, frequently coexists with comorbidities such as obesity and obstructive sleep apnea (OSA). The intricate relationship between AFib and OSA underscores...
Continue reading
A new wave of weight loss medications like Ozempic is changing the game for people struggling with obesity. These drugs, belonging to a class called GLP-1 receptor agonists, not only promote weight loss but also offer additional health benefits. By...
Continue reading
In the realm of sleep medicine, the efficacy of treatment modalities for obstructive sleep apnea (OSA) remains a crucial consideration, particularly when symptoms persist despite intervention. This case study presents the journey of a middle-aged man diagnosed with moderate OSA,...
Continue reading
Comorbid insomnia and sleep apnea (COMISA) is a double whammy for sleep. People with COMISA experience both insomnia, the difficulty falling or staying asleep, and sleep apnea, where breathing repeatedly stops and starts during sleep. These disorders worsen each other,...
Continue reading